1 |
BelimumabBelimumab, commonly known as Benlysta, is the first new drug therapy for lupus to be approved by the FDA in more than 50 years. Belimumab is a human antibody that inhibits B-cell activating factor (B [..]
|
2 |
Belimumab
A human monoclonal antibody that inhibits the biological activity of B-lymphocyte stimulator (BLyS).
|
<< B-lymphocyte stimulator | Biomarkers >> |